Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
Mario Muñoz Builes, María Vela Cuenca, Jose L Fuster Soler, Itziar Astigarraga, Antonia Pascual Martínez, Jose M Vagace Valero, Hoi Y Tong, Jaime Valentín Quiroga, Lucía Fernández Casanova, Adela Escudero López, Luisa Sisinni, Miguel Blanquer, Isabel Mirones Aguilar, Berta González Martínez, Alberto M Borobia, Antonio Pérez-Martínez
BMJ Open Jan 2020, 10 (1) e029642; DOI: 10.1136/bmjopen-2019-029642